399 related articles for article (PubMed ID: 26016761)
1. Tobacco differentially affects the clinical-biological phenotypes of ANCA-associated vasculitides.
Benarous L; Terrier B; Puéchal X; Dunogué B; Cohen P; Le Jeunne C; Mouthon L; Guillevin L;
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-116-21. PubMed ID: 26016761
[TBL] [Abstract][Full Text] [Related]
2. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
[TBL] [Abstract][Full Text] [Related]
3. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
[TBL] [Abstract][Full Text] [Related]
4. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
[TBL] [Abstract][Full Text] [Related]
5. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
[TBL] [Abstract][Full Text] [Related]
6. Association of antineutrophil cytoplasmic antibody (ANCA) specificity with demographic and clinical characteristics of patients with ANCA‑associated vasculitides.
Wójcik K; Masiak A; Jeleniewicz R; Jakuszko K; Brzosko I; Storoniak H; Kur-Zalewska J; Wisłowska M; Madej M; Hawrot-Kawecka A; Głuszko P; Kucharz EJ;
Pol Arch Intern Med; 2022 Mar; 132(3):. PubMed ID: 34985235
[TBL] [Abstract][Full Text] [Related]
7. Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts.
Pagnoux C; Carette S; Khalidi NA; Walsh M; Hiemstra TF; Cuthbertson D; Langford C; Hoffman G; Koening CL; Monach PA; Moreland L; Mouthon L; Seo P; Specks U; Ytterberg S; Westman K; Hoglund P; Harper L; Flossman O; Luqmani R; Savage CO; Rasmussen N; de Groot K; Tesar V; Jayne D; Merkel PA; Guillevin L;
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-77-83. PubMed ID: 26016754
[TBL] [Abstract][Full Text] [Related]
8. Childhood-Onset ANCA- Associated Vasculitis: single center experience from Central California.
Singh D; Sukumaran S
Pediatr Rheumatol Online J; 2023 Jul; 21(1):66. PubMed ID: 37400890
[TBL] [Abstract][Full Text] [Related]
9. ANCA-associated vasculitis in childhood: recent advances.
Calatroni M; Oliva E; Gianfreda D; Gregorini G; Allinovi M; Ramirez GA; Bozzolo EP; Monti S; Bracaglia C; Marucci G; Bodria M; Sinico RA; Pieruzzi F; Moroni G; Pastore S; Emmi G; Esposito P; Catanoso M; Barbano G; Bonanni A; Vaglio A
Ital J Pediatr; 2017 May; 43(1):46. PubMed ID: 28476172
[TBL] [Abstract][Full Text] [Related]
10. Seasonal Influence on Development of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Retrospective Cohort Study Conducted at Multiple Institutions in Japan (J-CANVAS).
Yoshida Y; Nakamoto N; Oka N; Kidoguchi G; Hosokawa Y; Araki K; Ishitoku M; Watanabe H; Sugimoto T; Mokuda S; Kida T; Yajima N; Omura S; Nakagomi D; Abe Y; Kadoya M; Takizawa N; Nomura A; Kukida Y; Kondo N; Yamano Y; Yanagida T; Endo K; Matsui K; Takeuchi T; Ichinose K; Kato M; Yanai R; Matsuo Y; Shimojima Y; Nishioka R; Okazaki R; Takata T; Ito T; Moriyama M; Takatani A; Miyawaki Y; Ito-Ihara T; Kawaguchi T; Kawahito Y; Hirata S
J Rheumatol; 2023 Sep; 50(9):1152-1158. PubMed ID: 37263656
[TBL] [Abstract][Full Text] [Related]
11. Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation.
Néel A; Espitia-Thibault A; Arrigoni PP; Volteau C; Rimbert M; Masseau A; Agard C; Fakhouri F; Liberge R; Hamidou M
Semin Arthritis Rheum; 2018 Aug; 48(1):70-76. PubMed ID: 29336783
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic relevance of cardiac involvement in ANCA-associated vasculitis: eosinophilic granulomatosis with polyangiitis and granulomatosis with polyangiitis.
Hazebroek MR; Kemna MJ; Schalla S; Sanders-van Wijk S; Gerretsen SC; Dennert R; Merken J; Kuznetsova T; Staessen JA; Brunner-La Rocca HP; van Paassen P; Cohen Tervaert JW; Heymans S
Int J Cardiol; 2015 Nov; 199():170-9. PubMed ID: 26209947
[TBL] [Abstract][Full Text] [Related]
13. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
[TBL] [Abstract][Full Text] [Related]
14. Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series.
Monti S; Montecucco C; Pieropan S; Mojoli F; Braschi A; Caporali R
Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-126-31. PubMed ID: 26016763
[TBL] [Abstract][Full Text] [Related]
15. Demographic and Clinical Features of ANCA-Associated Vasculitides in a Peruvian Tertiary Center.
Pimentel-Quiroz VR; Sánchez-Torres A; Acevedo-Vásquez E; Gamboa-Cárdenas RV; Reátegui-Sokolova C; Medina-Chinchón M; Zevallos F; Noriega-Zapata E; Alfaro-Lozano J; Cucho-Venegas JM; Sánchez-Schwartz C; Rodríguez-Bellido Z; Perich-Campos R; Pastor-Asurza CA; Alarcón GS; Ugarte-Gil MF
J Clin Rheumatol; 2021 Sep; 27(6S):S246-S251. PubMed ID: 33044385
[TBL] [Abstract][Full Text] [Related]
16. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
[TBL] [Abstract][Full Text] [Related]
17. The Association Between Age at Diagnosis and Disease Characteristics and Damage in Patients With ANCA-Associated Vasculitis.
Bloom JL; Pickett-Nairn K; Silveira L; Fuhlbrigge RC; Cuthbertson D; Akuthota P; Corbridge TC; Khalidi NA; Koening CL; Langford CA; McAlear CA; Monach PA; Moreland LW; Pagnoux C; Rhee RL; Seo P; Silver J; Specks U; Warrington KJ; Wechsler ME; Merkel PA;
Arthritis Rheumatol; 2023 Dec; 75(12):2216-2227. PubMed ID: 37433067
[TBL] [Abstract][Full Text] [Related]
18. Increasing incidence and prevalence of ANCA-associated vasculitis in Northern Norway.
Nilsen AT; Karlsen C; Bakland G; Watts R; Luqmani R; Koldingsnes W
Rheumatology (Oxford); 2020 Sep; 59(9):2316-2324. PubMed ID: 31859355
[TBL] [Abstract][Full Text] [Related]
19. Renal outcome of kidney-transplantation in Korean recipients with ANCA-associated vasculitis.
Park ES; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Exp Rheumatol; 2018; 36 Suppl 111(2):115-120. PubMed ID: 29185962
[TBL] [Abstract][Full Text] [Related]
20. Methotrexate versus cyclophosphamide for remission maintenance in ANCA-associated vasculitis: A randomised trial.
Maritati F; Alberici F; Oliva E; Urban ML; Palmisano A; Santarsia F; Andrulli S; Pavone L; Pesci A; Grasselli C; Santi R; Tumiati B; Manenti L; Buzio C; Vaglio A
PLoS One; 2017; 12(10):e0185880. PubMed ID: 29016646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
